Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 15, 2018

Total Value: $797M (99.2% shares, 0.8% debt)

Holdings (17)

INGN INOGEN INC 54.7%

Value $436M Shares 3,549,320 Est. Cost $17.78 Unrealized +586.6%

— ACCELERON PHARMA INC 7.6%

Value $60.76M Shares 1,553,937 Est. Cost $27.65 Unrealized —

— MENLO THERAPEUTICS INC 6.4%

Value $51.16M Shares 1,361,313 Est. Cost $37.58 Unrealized —

CRVS CORVUS PHARMACEUTICALS INC 6.4%

Value $50.97M Shares 4,420,516 Est. Cost $13.03 Unrealized -27.4%

— UNUM THERAPEUTICS INC 4.0%

Value $31.67M Shares 665,181 Est. Cost $47.61 Unrealized —

AKBA AKEBIA THERAPEUTICS INC 3.7%

Value $29.54M Shares 3,100,000 Est. Cost $12.34 Unrealized +13.4%

— MERUS N V 3.3%

Value $26.14M Shares 1,410,417 Est. Cost $7.99 Unrealized —

GKOS GLAUKOS CORP 2.2%

Value $17.42M Shares 565,165 Est. Cost $30.14 Unrealized +0.5%

— DERMIRA INC 2.0%

Value $15.93M Shares 1,993,746 Est. Cost $30.14 Unrealized —

— VERONA PHARMA PLC 1.9%

Value $14.81M Shares 740,740 Est. Cost $11.66 Unrealized —

— NABRIVA THERAPEUTICS PLC 1.8%

Value $14.71M Shares 2,924,822 Est. Cost $10.02 Unrealized —

CRSP CRISPR THERAPEUTICS AG 1.3%

Value $10.21M Shares 223,317 Est. Cost $18.69 Unrealized +120.8%

KIDS ORTHOPEDIATRICS INC 1.2%

Value $9.406M Shares 624,591 Est. Cost $18.57 Unrealized -4.6%

— SEASPINE HLDGS CORP 1.2%

Value $9.333M Shares 920,380 Est. Cost $10.14 Unrealized —

— RA PHARMACEUTICALS INC 1.0%

Value $7.784M Shares 1,465,838 Est. Cost $15.19 Unrealized —

— WRIGHT MED GROUP N V 0.8%

Value $6.332M Shares 4,622,032 Est. Cost $1.25 Unrealized —

— INVUITY INC 0.7%

Value $5.251M Shares 1,363,848 Est. Cost $9.51 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
INGN	INOGEN INC	3,549,320	$436M	54.7%	$17.78	+586.6%	COM	45780L104
—	ACCELERON PHARMA INC	1,553,937	$60.76M	7.6%	$27.65	—	COM	00434H108
—	MENLO THERAPEUTICS INC	1,361,313	$51.16M	6.4%	$37.58	—	COM	586858102
CRVS	CORVUS PHARMACEUTICALS INC	4,420,516	$50.97M	6.4%	$13.03	-27.4%	COM	221015100
—	UNUM THERAPEUTICS INC	665,181	$31.67M	4.0%	$47.61	—	COM	903214104
AKBA	AKEBIA THERAPEUTICS INC	3,100,000	$29.54M	3.7%	$12.34	+13.4%	COM	00972D105
—	MERUS N V	1,410,417	$26.14M	3.3%	$7.99	—	COM	N5749R100
GKOS	GLAUKOS CORP	565,165	$17.42M	2.2%	$30.14	+0.5%	COM	377322102
—	DERMIRA INC	1,993,746	$15.93M	2.0%	$30.14	—	COM	24983L104
—	VERONA PHARMA PLC	740,740	$14.81M	1.9%	$11.66	—	SPONSORED ADS	925050106
—	NABRIVA THERAPEUTICS PLC	2,924,822	$14.71M	1.8%	$10.02	—	SHS	G63637105
CRSP	CRISPR THERAPEUTICS AG	223,317	$10.21M	1.3%	$18.69	+120.8%	NAMEN AKT	H17182108
KIDS	ORTHOPEDIATRICS INC	624,591	$9.406M	1.2%	$18.57	-4.6%	COM	68752L100
—	SEASPINE HLDGS CORP	920,380	$9.333M	1.2%	$10.14	—	COM	81255T108
—	RA PHARMACEUTICALS INC	1,465,838	$7.784M	1.0%	$15.19	—	COM	74933V108
—	WRIGHT MED GROUP N V	4,622,032	$6.332M	0.8%	$1.25	—	RIGHT 03/01/2019	N96617126
—	INVUITY INC	1,363,848	$5.251M	0.7%	$9.51	—	COM NEW	46187J205